Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 14/12/2017
SIETES contiene 92152 citas

 
 
 1 a 20 de 453 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Ford BM, Tai S, Fantegrossi WE, Prather PL. Synthetic pot: not your grandfathers marijuana. Trends Pharmacol Sci 2017;38:257-76. [Ref.ID 101989]
2. Cita con resumen
Dimmitt S, Stampfer H, Martin JH. When less is more – Efficacy with less toxicity at the ED50. Br J Clin Pharmacol 2017;83:1365-8. [Ref.ID 101984]
3. Cita con resumen
Aronson J. When I use a word... Safety. BMJ 2015;351:h3521. [Ref.ID 99245]
4. Cita con resumen
Aronson J. Safety. BMJ 2015;351:h3521. [Ref.ID 99243]
5. Cita con resumen
Goodman JL. Studying “secret serums” — Toward safe, effective Ebola treatments. N Engl J Med 2013;371:1086-9. [Ref.ID 97858]
6.Enlace a cita original
Rawlins MD. Clinical pharmacology in health care, teaching and research. Br J Clin Pharmacol 2013;75:1219-20. [Ref.ID 95328]
7.Tiene citas relacionadas Cita con resumen
Evans SJW. An agenda for UK clinical pharmacology: pharmacoepidemiology. Br J Clin Pharmacol 2012;73:973-8. [Ref.ID 93098]
8.Enlace a cita original
Aronson JK. What do clinical pharmacologists do? A questionnaire survey of senior UK clinical pharmacologists. Br J Clin Pharmacol 2012;73:161-9. [Ref.ID 92422]
9. Cita con resumen
Taegtmeyer AB, Curkovic I, Rufibach K, Corti N, Battegay E, Kullak-Ublick GA. Electronic prescribing increases uptake of clinical pharmacologists' recommendations in the hospital setting. Br J Clin Pharmacol 2011;72:958-64. [Ref.ID 91875]
10.Enlace a cita originalTiene citas relacionadas
Kazmi RS, Lwaleed BA. New anticoagulants: how to deal with treatment failure and bleeding complications. Br J Clin Pharmacol 2011;72:593-603. [Ref.ID 91566]
11.Enlace a cita originalTiene citas relacionadas
Lee CJ, Ansell JE. Direct thrombin inhibitors. Br J Clin Pharmacol 2011;72:581-92. [Ref.ID 91565]
12.Enlace a cita originalTiene citas relacionadas
Toschi V, Lettino M. Inhibitors of propagation of coagulation: factors V and X. Eur J Clin Pharmacol 2011;72:563-80. [Ref.ID 91564]
13.Enlace a cita originalTiene citas relacionadas
Franchini M, Mannucci PM. Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice. Eur J Clin Pharmacol 2011;72:553-62. [Ref.ID 91563]
14.Enlace a cita originalTiene citas relacionadas
Ott I. Inhibitors of the initiation of coagulation. Eur J Clin Pharmacol 2011;72:547-52. [Ref.ID 91562]
15.Enlace a cita originalTiene citas relacionadas
Kluft C, Burggraaf J. Introduction to haemostasis from a pharmacodynamic perspective. Eur J Clin Pharmacol 2011;72:538-46. [Ref.ID 91561]
16.
Zakar T, Mesiano S. How does progesterone relax the uterus in pregnancy?. N Engl J Med 2011;364:972-3. [Ref.ID 90635]
17.Tiene citas relacionadas
Aronson JK. Integrating pharmacology and clinical pharmacology. Br J Clin Pharmacol 2011;71:787-90. [Ref.ID 90608]
18.Tiene citas relacionadas Cita con resumen
Tucker GT, Miners JO. What's in a name?. Br J Clin Pharmacol 2011;71:785-6. [Ref.ID 90607]
19.Enlace a cita original
Laporte JR, Llop R, Bosch M. Avenços que canvien la pràctica clínica. Annals Med (Barc) 2011;94:S3-S10. [Ref.ID 90417]
20. Cita con resumen
Hamburg MA. Innovation, regulation, and the FDA. N Engl J Med 2010;363:2228-32. [Ref.ID 89748]
Seleccionar todas
 
 1 a 20 de 453 siguiente >>